Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of HCV genotype on treatment regimens and drug resistance: a snapshot in time.

Reviews in medical virology - 1 Nov 2016

Cuypers Lize, Ceccherini-Silberstein Francesca, Van Laethem Kristel, Li Guangdi, Vandamme Anne-Mieke, Rockstroh Jürgen Kurt

Abstract excerpt

The introduction of highly potent direct-acting antivirals (DAAs) has revolutionized hepatitis C virus treatment. Nevertheless, viral eradication worldwide remains a challenge also in the era of DAA treatment, because of the high associated costs, high numbers of undiagnosed patients, high re-infection rates in some risk groups and suboptimal drug efficacies associated with host and viral factors as well as...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Drug Resistance, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotyping Techniques

Share to Hepacivirus

Share to Hepatitis C, Chronic

Share to Microbial Sensitivity Tests

Share to Selection, Genetic

Share to Treatment Outcome

Source

Identifiers

PMID: 27401933
DOI: 10.1002/rmv.1895

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of HCV genotype on treatment regimens and drug resistance: a snapshot in time.PMID 27401933Read ↗

Key points for the management of hepatitis C in the era of pan-genotypic direct-acting antiviral therapySemantic proximity Read ↗

Emerging therapies for hepatitis C virus (HCV) infection: the importance of HCV genotype.Semantic proximity Read ↗

Hepatitis C Virus: Viral Quasispecies and Genotypes.Semantic proximity Read ↗

'Unusual' HCV genotype subtypes: origin, distribution, sensitivity to direct-acting antiviral drugs and behaviour on antiviral treatment and retreatment.Semantic proximity Read ↗

Pan‐genotypic treatment regimens for hepatitis C virus: Advantages and disadvantages in high‐ and low‐income regionsSemantic proximity Read ↗

New hepatitis C therapies: the toolbox, strategies, and challenges.Semantic proximity Read ↗

Worldwide prevalence, genotype distribution and management of hepatitis C.Semantic proximity Read ↗

Worldwide prevalence of baseline resistance-associated polymorphisms and resistance mutations in HCV against current direct-acting antivirals.Semantic proximity Read ↗

Clinical impact of the hepatitis C virus mutations in the era of directly acting antivirals.Semantic proximity Read ↗

Virologic Tools for HCV Drug Resistance TestingSemantic proximity Read ↗

[Clinical significance of drug resistance-associated mutations in treatment of hepatitis C with direct-acting antiviral agents].Semantic proximity Read ↗

Optimal cure rate by personalized HCV regimens in real-life: a proof-of-concept study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.